Submit your comments on this article |
Europe |
Belgian restrospective study: HCQ saved lives |
2020-08-27 |
[ScienceDirect] Of 8075 patients with complete discharge data on 24th of May and diagnosed before the 1st of May, 4542 received HCQ in monotherapy and 3533 were in the no-HCQ group. Death was reported in 804/4542 (17.7%) and 957/3533 (27.1%), respectively. [this is HCQ, low dose, i.e. 2400mg over 5 days, without zinc or an antibacterial] |
Posted by:lord garth |